Cardiac allograft microvascular dysfunction correlates with a peripheral marker of immunocyte activation  by Bach, Richard G. et al.
:I- 
U 
E 
S 
D 
A, 
Y 
P 
0 
S 
T 
E 
R 
206A ABSTRACTS-Poster .IACC February 1996 
patients (HT pits) on CyA therapy and healthy volunteers (NL pits). When 
CyA pitS and NL pits (1 x 10 a cellgml) were thrombin activated and perfused 
through a quiescent, N~-nltm-L-arglnine pre-treated normal rabbit carotid 
artery, pits caused a similar degree of vasoconstriction: -8.9 ± 2% vs. -8.8 
± 2% change in vessel diameter (CIVD), respectively (n = 7, p = NS). There 
was no dilferanco in the amount of ADP released into the supematar-tt of 
thromhin activated CyA pits and NL pits. However, while NL pits had no effect, 
activated CyA pits impaired endO~eflurn-dopendent vesedifation mediated 
by graded doses of abfuminally applied acetylcholine (Ach): 6 + 6% vs. 17 
5=/o, t3 :E g% vs. 44 4-13% and 43:1:13°/= vs. 78--.+. 8% CIVD, with Ps. w~hout 
concominant pit pertusion, for 10 -s, 10 -7 and 10 .8 MAch, reapectively (n 
: 4, p < 0.05). Dtmsthyithiourea (DMTU), a lipid soluble hydroxyl ~¢l~cal 
scavenger restored the ability of CyA pits to mediate vesodilalion: 17 :E 
7=/= ,vs. -4.5 4- 1.4% CWD, (n = 7, p < 0.05), while superoxlde dismutase 
(SOD) and catalase did not. Similarly, DMTU restored the ability of CyA 
exposed NL pits to cause vasedilalion, wh~e SOD and catslase did not. 
Condusion: Activated CyA-pits release free radical(s) which interfere with 
piatslstomedialed endothelium-dapendant vasndilatlon. 
1945--'4"5~ Discordant Effects o f  Acetylchollne, Substance P, 
end Adenosine in the Assessment o f  Cardiac 
AUograft Endothelial Function 
John H. Drury, Thomas Donohue, Rtcherd G. Bach, Leslie W. Miller, Morton 
J. Kern, Thomas L. Wolford. St. Louis University Health Sciences Center, 
St. Louis, MO 
Endothelial dysfunction is considered central to the pathogenesis of trans- 
plant coronary arteriopethy. Previous studies have used Acetylcholine (ACH) 
or Substance P (SP) to assess allograft coronary endothelium Integrity with 
conflicting results. Therefore, to study these agents in the same allagraft, we 
compared eplcardial vessel diameter (EVD) and coronary blood flow (CBF) 
responses to intracoronary infusions of ACN (10 -6 M), SP (22.4 pmoles), 
Adenosine (ADEN 10 -= M) and Saline (CON) in 18 transplant recipients (5.1 
+ 2.8 yrs post-transplant). A total of 54 segments were analyzed (3/pt). Mid 
segment EVD (quantitative coronary angiography) and blood flow velocity 
(Doppler guidewire) were used to derive CBF (average peak velocity x 0.5 
x cress-sectional area). 
ACH SP ADEN CON 
%AEVD 0.3±1.8 7.94-1.8" 12.64-2.1 0.94-1~0 
%ACBF 180±26" 164-9 § 3784-34 4.7±3.4 
*p = 0.005 vs ACH, "p:  0.02 v,J ADEN, §p = NS vS CON, §p < 0.0001 vs ACH. **p - 0. 
002 vs ADEN 
Cardiac allografts had abnormal epicardial vessel responses to ACH 
yet exhibited preserved endothelium-dependent epicardial vasodilation to 
SP and flow {ADEN). There were discordant CBF responses to the two 
endsthalial-dependent agents with an intact response to ADEN. Flow-mediated 
vasodilafory effects must be considered when using AGH to evaluate en- 
dothelial function. These discordant respenses must also be considered 
when these agents are used to characterize ndothelial integrity in the hu- 
man cardiac aifograft. 
~ R o l e  of Nitric Oxide in Myocardial  Ischemla and 
Reperfuaion Injury in • Heterotopic Rat Heart 
Transplantation Model 
Gaber Szal~, Sander B~it~i, Ralner Zlmmerrnann, Siegfried Hagl. 
University of Heidelberg, Germany 
Global myocardial ischemla and repeduslon injury play a major role In early 
postoperative graft dysfunction. In the present study, the influence of nt- 
trio oxide (NO) on ischemle/raporfusion injury and catochalamine sensitivity 
was investigated In a hetemtopic rat heart transplantation model. After one 
hour ischemlc preservation, reperfusion was started either after application 
of placebo (n = 8, control) or nltro-L-arginlne methyl ester (L-NAME, 10 
mg/kg, n = 8) for inhibition of NO synthesis. Myocardial blood flow (MBF), 
left vantdcular pressure (LVP), its first derivative (dP/dt), end diastOlic pres- 
sure (LVEOP) and lsovolumic relaxation constant O's) were measured after 
60 minutes reperfusion and with subsequent dobutamine (O) infusion (5 
/zg/kg/min). One,day graft survival was decreased after L-NAME (5•8 after 
L-NAME vs 8/8 in control). MBF was significantly decreased after L-NAME 
(1.2 4- 0.1 ve 1.g =t: 0.2 mVmlrVg, p < 0.05). The L-NAME group showed a 
decreased systolic function (maximal LVP: 53.2 4- 6 vs 86.5 ± 7 mmHg, p < 
0.05; maximal dP/dt: 1257 ± 290 vs 3410 4- 257 mmHg/s, p < 0.05) and a 
significant leftward shift of the LVEDP-Isft ventricular volume curve (LVEDP: 
12.57 ~- 1.4 vs 4.76 ~ 0.8 mmHg, p < 0.05 at a reference volume of 80 ,#). 
Myocardial relaxation was prolonged after L-NAME (TE: 23.8 -4- 3.1 vs 11.3 
± 1.6 ms, p < 0.05). D increased LVP, dP/dt and"Is in beth groups, however, 
this increase was smaller in the L-NAME group (p < 0.05). MBF remained 
unchanged with O In the L-NAME group and increased in the control group 
(1.2 ± 0.2 vs 2.7 4- 1.9 vs ml/mln/g, p < 0.05). These results indicate that 
1) NO productton within the graft during repeduslon represents a substan- 
tial determinant of graft function, 2) NO formation plays an Important role 
in #.edrenerglc responses of the mtcrevasculafure in the graft after heart 
transplantation. 
Cardiac AIIograft Mlcrovesculer Dysfunction 
uorraletes With • Peripheral Marker of  
Immunocyte Actlvctlon 
Richard G. Bach, Thomas Wolford, Thomas J. Donohue, John H. Drury, 
Eugene A. Carascloto, Frank V. Agulrre, Morton J. Kern, Leslie W. Miller. St. 
Louis University, St. Louis, MO 
Attograft artoriopathy after heart transplantation can involve beth eptcardial 
conduit and resistance vessels. The etiology remains unknown, although 
recent data has implicated an immunologic mechanism. To date, few studies 
have examined allogralt microvascular functional abnormalities. Therefore, 
we examined the association between abnormal allagraft coronary vasodila- 
for reserve (CVR) detected uring routine transplant follow-up and markers 
of immune activation. CVR (hyperemic/basal mean flow velocity) was de- 
termined by Doppler guidewire and adenosine in 347 coronary arteries in 
170 pts at catheterization. Peripheral blood was analyzed by flow cytome- 
try for determination of percentage of activated T cells (T4 cells expressing 
Interleukin-2 receptor by anti-CD25, % T4-1L2R+). Concurrent biopsy re- 
jection grade (numerical conversion of ISHLT grade, BxGRD) and number 
of previous treated rejection episodes (#+REJ) were also analyzed. CVR 
was considered abnormal at < 2.0 (> 1SD below mean In normal artedas). 
Results (mean :1= SEM): 
(n) # + REJ B x GRD % T4-1L2R+ 
CVR > 2.0 312 1.9 4. 0.1 1.04. 0.1 10.0 + 1 
C~ < 2.0 ~ ~.~ ~ ~1 ~ 1.2±0.2 22.54-3 
p value 0.as 0.41 0.00S 
Notably, % T4-1L2R+ was significantly higher when CVR was reduced 
at < 2.0. Reduced CVR was not correlated with acute cellular rejection or 
with a history of previously treated rejection episodes. These results suggest 
that microvascular dysfunction in cardiac allografts may result from activated 
T-cog-mediated mechanisms, independent of rejection, of which peripheral 
IL-2R quantitatlon may provide a useful marker. 
Inducible Nitric Oxide Synthase Is Expressed 
uurmg P.arly and Late Experimental Acute Cardiac 
AIIograft Rejection 
Nell K. Worrall, Thomas P. Misko, Jia J. Hut, Patrick M. Sullivan, T. 
Bruce Ferguson Jr.. Washington University, St. Louis, 1t40; Monsanto Co., 
St. Louis, MO 
We have recently demonstrated that 1 ) inducible nitric oxide synthase (iNOS) 
is expressed dudng acute cardiac allograft rejection end 2) inhibition of nitric 
oxide (NO) production by iNOS attenuates acute rejection. This study deter- 
mined the time-coume of INOB mRNA and protein expression dudng acute 
rejection. Using a hetsmfopic rat model, grafted heart tissue from isogrefts 
(ACI to ACI) and allagrefts (Lewis to ACI) was harvested at serial time-points 
pest-tranaplantstion. INO$ mRNA (detected by dbonuctease protection as- 
say) was weakly present in allogrefts on POD-3 (minimal rejection), was 
strongly present on POD-4, -6, -8, and -10 (mild to complete rejection, re- 
spectively), but was not present in isogrefts on POD-6 or -8 or in normal 
controls, iNOS enzyme activity (measured as conversion of L-[ a H]-arginine 
to NO and L-p H]-citrulline) was higher in allagrefts on POD-4, -6, -8, and 
-10 (9.0:1: 2.3, 5.1 4- 1.0, 5.7 =1: 1.6, and 4.3 • 0.7 pmol L-citrulllne/mg 
protein/rain, respectively) than in aifografts on POD-3 (0.6 4- 0.3), in isografts 
on POD-6 or-8 (0.1 ± 0.1 and 0.2 4- 0.1), or in controls (0.1 d: 0.1; mean 
4- SEM; n = 4-8; P < 0.01 by ANOVA). Serum nltdte/nltrete l vels, which 
reflect endogenous NO production, were higher in allografts on POD-4, -6, 
and -8 (45 4- 7, 57:1: 5, and 33 4- 1 p.M, respectively) than in allografts on 
POD-3 (20 :t: 2), in isografts on POD-4, -6 or .8 (22 4- 2, 22 4- 4, and 14 4- 
1), or in controls (15 ± 1; mean :l: SEM; n = 4--12; P < 0.01 by ANOVA). 
Thus INOS mRNA and protein expression first occur dudng the early stages 
of acute rejection and pore{st throughout he unmodified rejection process. 
Increased NO production, detected by the presence of INOS mRNA, protein, 
or noninvasively by measuring serum nitdte/nitrste l vels, may ,;'erve as an 
early marker of acute cardiac altograft rejection. 
